Evaluation of the CONVIVO System
Clinical Investigation to Evaluate the CONVIVO System for Discrimination of Normal From Abnormal Tissue During Brain Tumor Resection
Sponsor: Carl Zeiss Meditec, Inc.
A NA clinical study on Brain Metastases and Glial Tumor, this trial is actively recruiting participants. The trial is conducted by Carl Zeiss Meditec, Inc. and has accumulated 6 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Feb 2026 — Present [monthly]
Recruiting NA
-
Sep 2024 — Feb 2026 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Sep 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2022 — Sep 2023 [monthly]
Not Yet Recruiting NA
▶ Show 1 earlier version
-
Jan 2022 — Mar 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Carl Zeiss Meditec, Inc.
- Dartmouth-Hitchcock Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .